Kaiser Permanente Ventures
Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Business Model:
Revenue: $15M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kaiser Permanente Ventures Information
Geographic Data
Address: 1 Kaiser Plaza
City: Oakland
State: CA
Zip: 94612
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$141M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 11/2001 | NextWeb | Series C | - |
| 4/2014 | Omada Health | Series B | 23M |
| 3/2012 | AtheroMed | Series D | 4.5M |
| 9/2009 | ValenTx | Series B | 0 |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 8/2020 | Freenome | Series C | 270M |
| 8/2022 | Everytable | Series C | 0 |
| 10/2008 | Predictive Biosciences | Series B | 21.8M |
| 9/2011 | Valeritas | Series C | 150M |
| 7/2021 | Osso VR | Series B | 0 |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 4/2022 | IntelyCare | Series C | 0 |
| 4/2007 | Bacchus Vascular | Venture Round | 6.5M |
| 4/2014 | Transcend Medical | Series C | 0 |
| 8/2009 | Silverlink Communications | Series D | 5M |
| 1/2022 | Big Health | Series C | 0 |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 7/2019 | Nuvolo | Series B | 12M |
| 9/2022 | Kate Farms | Series C | 75M |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 9/2013 | Xanitos | Venture Round | 0 |
| 2/2009 | Arcxis Biotechnologies | Series B | - |
| 1/2007 | Calypso Medical | Series D | 42.2M |
| 12/2015 | Vidyo | Series E | 15M |
| 6/2010 | Baxano | Series C | 30M |
| 3/2020 | Ordr | Series B | 6M |
| 6/2016 | Bluesight | Series C | 20.4M |
| 2/2020 | IntelyCare | Series B | 45M |
| 3/2021 | Evidation Health | Series E | 153M |
| 1/2015 | Bluesight | Series B | 12M |
| 4/2015 | Validic | Series B | 12.5M |
| 6/2020 | Big Health | Series B | 39M |
| 11/2020 | Everytable | Series B | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 1/2014 | Health Catalyst | Series C | 0 |
| 10/2022 | NorthOne | Series B | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 2/2008 | Accumetrics | Series D | 0 |
| 11/2015 | Vapotherm | Series C | 0 |
| 7/2019 | Freenome | Series B | 160M |
| 4/2013 | Vapotherm | Series A | 0 |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 6/2012 | TriVascular | Series D | 60M |
| 7/2014 | Valeritas | Series D | 45M |
| 8/2021 | Genome Medical | Series C | 0 |
| 9/2019 | Ginger | Series C | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 3/2021 | Nuvolo | Series C | 32M |
| 3/2015 | Health Catalyst | Series D | 0 |
| 1/2023 | NOCD | Series B | 0 |
| 7/2017 | Protenus | Series A | 3M |
| 3/2021 | DexCare | Series A | 0 |
| 6/2023 | DexCare | Series C | 0 |
| 7/2015 | Vapotherm | Series C | 0 |
| 11/2017 | Collective Medical Technologies | Series A | 47.5M |
| 11/2013 | TriVascular | Series E | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 11/2007 | Vapotherm | Series E | 11.3M |
| 8/2008 | Vapotherm | Series F | 20.5M |
| 9/2014 | MetricStream | Private Equity Round | 60M |
| 1/2005 | CHF Solutions | Venture Round | 22.9M |
| 9/2012 | Torax Medical | Series D | 0 |
| 9/2020 | Osso VR | Series A | 14M |
| 3/2013 | Health Catalyst | Series B | 0 |
| 5/2010 | Oxford Immunotec | Series D | 26M |
| 11/2002 | NextWeb | Series D | 1.5M |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 7/2020 | Genome Medical | Series B | 0 |
| 3/2012 | GluMetrics | Venture Round | 13.3M |
| 9/2021 | NOCD | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
| 1/2013 | Nordic | Funding Round | 38.3M |
| 1/2018 | Protenus | Series B | 11M |
| 4/2005 | BDNA | Series C | 12.5M |
| 6/2010 | Predictive Biosciences | Series C | 25M |
| 1/2012 | CytoPherx | Series C | 34M |
| 8/2020 | Ginger | Series D | 0 |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 1/2015 | Kit Check | Series B | 12M |
| 8/2005 | NextWeb | Series E | 3.5M |
| 8/2019 | Protenus | Series C | 0 |
| 6/2016 | Kit Check | Series C | 0 |
| 4/2013 | iRhythm Technologies | Series D | 16M |
| 1/2012 | iRhythm Technologies | Private Equity Round | 12.2M |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 4/2014 | Vapotherm | Series B | 0 |
| 8/2005 | Adiana | Series D | 23M |
| 6/2013 | Movable | Seed | 1.9M |
| 9/2010 | Accumetrics | Venture Round | 0 |
| 10/2009 | Accumetrics | Series E | 0 |
| 1/2012 | Transcend Medical | Series B | 16M |
| 4/2013 | Nordic | Venture Round | 5M |
| 7/2016 | Big Health | Series B | 0 |
| 12/2014 | Ginger | Series B | 20M |
| 4/2013 | AtheroMed | Private Equity Round | 6M |
| 12/2004 | Radianse | Venture Round | 2M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 2/2016 | CareGuardian | Series B | 5M |
| 11/2022 | Validic | Venture Round | 12M |
| 1/2015 | Ingenious Med | Venture Round | - |
| 1/2018 | Genome Medical | Series A | 11M |
| 11/2011 | Xanitos | Venture Round | 0 |
| 6/2011 | Transcend Medical | Series B | 51M |
| 11/2020 | Kate Farms | Series B | 51M |
| 7/2016 | Torax Medical | Series E | 0 |
| 8/2022 | Everytable | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 9/2021 | NOCD | Series B | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 7/2021 | Osso VR | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
